Invesco Pharmaceuticals ETF Rating $81.57 +1.42 (+1.77%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PJP Aggregate RatingModerate Buy 2.68Holdings in PJP have an aggregate rating of Moderate Buy based on 393 analyst ratings issued in the past year covering 30 companies (100.0% of the portfolio).PJP Aggregate Price Target$81.57High Prediction$81.57Average Prediction$81.57Low Prediction$81.57Holdings in PJP have an aggregate price target of $81.57 and a range of $81.57 to $81.57 covering 30 companies (100.0% of the portfolio).PJP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 PJP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.35%ABTAbbott Laboratories$133.61-0.2%4.8724 of 5 stars2.84$142.59 6.7%19Positive News5.33%GILDGilead Sciences$112.46+1.8%4.7217 of 5 stars2.78$110.55 -1.7%27Positive News5.10%JNJJohnson & Johnson$155.02+0.9%4.8582 of 5 stars2.55$170.88 10.2%20Positive NewsAnalyst Forecast4.97%ABBVAbbVie$189.89+1.3%4.8531 of 5 stars2.81$212.19 11.7%27Positive News4.83%PFEPfizer$23.36+1.0%4.9933 of 5 stars2.53$29.17 24.9%15Trending News4.76%AMGNAmgen$290.33+1.1%4.1772 of 5 stars2.38$309.22 6.5%24Positive News4.70%MRKMerck & Co., Inc.$78.95+1.7%4.997 of 5 stars2.43$109.19 38.3%21Positive News4.38%LLYEli Lilly and Company$770.00+0.6%4.9888 of 5 stars2.76$1,011.37 31.3%21Positive NewsAnalyst Downgrade3.88%CORTCorcept Therapeutics$69.60+0.9%4.7113 of 5 stars3.00$138.25 98.6%5Insider Trade3.20%ANIPANI Pharmaceuticals$61.96+3.5%4.7956 of 5 stars3.00$80.13 29.3%9Positive News3.18%PRGOPerrigo$26.18+0.8%4.9657 of 5 stars2.25$33.00 26.1%43.18%INVAInnoviva$21.58+1.9%4.5077 of 5 stars3.00$55.00 154.9%2Positive News3.14%TARSTarsus Pharmaceuticals$43.92-0.4%2.772 of 5 stars3.00$66.67 51.8%73.10%PCRXPacira BioSciences$25.97-2.9%3.0367 of 5 stars2.33$26.44 1.8%9Positive NewsInsider Trade3.02%COLLCollegium Pharmaceutical$30.20+2.4%3.9767 of 5 stars2.80$43.80 45.0%5Positive News2.99%LQDALiquidia$18.14+0.7%3.6461 of 5 stars3.00$26.67 47.0%92.96%PBHPrestige Consumer Healthcare$85.11+0.6%3.6079 of 5 stars2.50$93.33 9.7%6Positive News2.95%SUPNSupernus Pharmaceuticals$33.15+2.5%1.5269 of 5 stars2.33$36.00 8.6%3Positive News2.79%HRMYHarmony Biosciences$35.60+1.6%4.9455 of 5 stars3.11$53.00 48.9%9Positive News2.64%BIIBBiogen$133.13+2.1%4.7292 of 5 stars2.38$191.30 43.7%322.59%UTHRUnited Therapeutics$325.82+1.9%4.847 of 5 stars2.69$393.00 20.6%13Positive NewsAnalyst Revision2.58%LGNDLigand Pharmaceuticals$105.99+1.7%4.8448 of 5 stars3.00$146.14 37.9%7Positive News2.54%AMRXAmneal Pharmaceuticals$7.62+6.3%3.5286 of 5 stars3.00$11.60 52.2%5News CoveragePositive NewsAnalyst Forecast2.45%REGNRegeneron Pharmaceuticals$493.22+2.1%4.8396 of 5 stars2.85$844.48 71.2%26Analyst Forecast2.42%BMYBristol-Myers Squibb$48.42+1.2%4.733 of 5 stars2.32$58.00 19.8%222.33%JAZZJazz Pharmaceuticals$111.13+2.1%4.9127 of 5 stars2.92$184.00 65.6%13Positive NewsAnalyst Forecast2.32%TVTXTravere Therapeutics$15.32+4.1%2.5313 of 5 stars2.87$31.79 107.5%152.30%AMPHAmphastar Pharmaceuticals$25.99+1.8%3.8058 of 5 stars2.25$32.33 24.4%4Positive NewsShort Interest ↑2.18%VTRSViatris$8.71+3.0%2.1707 of 5 stars1.80$10.40 19.4%5Analyst ForecastGap Down1.84%GERNGeron$1.60+2.6%3.2195 of 5 stars2.78$5.06 216.4%9Positive News This page (NYSEARCA:PJP) was last updated on 6/6/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredTrump’s Wealth Reset: Could You Be The First Beneficiary?Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major shift is coming this July — and Wall Street isn't waiting around. Thanks to a new rule going into e...American Alternative | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PJP Stock Free PJP Stock Alerts